Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
Patricia Udaondo1,2, Salvador Garcia-Delpech1,3, David Salom1,3, Maria Garcia-Pous1,3, Manuel Diaz-Llopis1,31Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain; 2University Cardenal Herrera CEU, Valencia, Spain; 3Faculty of Medicine, University of Valencia, Valencia, SpainPurpose: To...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c39c876695004519b25417e3291cafda |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c39c876695004519b25417e3291cafda |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c39c876695004519b25417e3291cafda2021-12-02T11:21:05ZIntravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion1177-54671177-5483https://doaj.org/article/c39c876695004519b25417e3291cafda2011-07-01T00:00:00Zhttp://www.dovepress.com/intravitreal-pegaptanib-for-refractory-macular-edema-secondary-to-reti-a7821https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Patricia Udaondo1,2, Salvador Garcia-Delpech1,3, David Salom1,3, Maria Garcia-Pous1,3, Manuel Diaz-Llopis1,31Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain; 2University Cardenal Herrera CEU, Valencia, Spain; 3Faculty of Medicine, University of Valencia, Valencia, SpainPurpose: To assess the efficacy of intravitreal Pegaptanib sodium (Macugen®) injection in the management of refractory macular edema secondary to branch retinal vein occlusion.Methods: This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema refractory to either bevacizumab or triamcinolone were treated with intravitreal injection of Pegaptanib sodium.Results: After three months follow-up, both visual acuity and macular edema, measured by optical coherence tomography and fluorescence angiography, dramatically improved.Conclusion: Pegaptanib sodium is a safe and efficacy treatment for macular edema secondary to branch retinal vein occlusion.Keywords: Macugen®, BRVO, BCVA, pegaptanib sodiumUdaondo PGarcia-Delpech SSalom DGarcia-Pous MDiaz-Llopis M.Dove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 941-944 (2011) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ophthalmology RE1-994 |
spellingShingle |
Ophthalmology RE1-994 Udaondo P Garcia-Delpech S Salom D Garcia-Pous M Diaz-Llopis M. Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion |
description |
Patricia Udaondo1,2, Salvador Garcia-Delpech1,3, David Salom1,3, Maria Garcia-Pous1,3, Manuel Diaz-Llopis1,31Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain; 2University Cardenal Herrera CEU, Valencia, Spain; 3Faculty of Medicine, University of Valencia, Valencia, SpainPurpose: To assess the efficacy of intravitreal Pegaptanib sodium (Macugen®) injection in the management of refractory macular edema secondary to branch retinal vein occlusion.Methods: This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema refractory to either bevacizumab or triamcinolone were treated with intravitreal injection of Pegaptanib sodium.Results: After three months follow-up, both visual acuity and macular edema, measured by optical coherence tomography and fluorescence angiography, dramatically improved.Conclusion: Pegaptanib sodium is a safe and efficacy treatment for macular edema secondary to branch retinal vein occlusion.Keywords: Macugen®, BRVO, BCVA, pegaptanib sodium |
format |
article |
author |
Udaondo P Garcia-Delpech S Salom D Garcia-Pous M Diaz-Llopis M. |
author_facet |
Udaondo P Garcia-Delpech S Salom D Garcia-Pous M Diaz-Llopis M. |
author_sort |
Udaondo P |
title |
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion |
title_short |
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion |
title_full |
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion |
title_fullStr |
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion |
title_full_unstemmed |
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion |
title_sort |
intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion |
publisher |
Dove Medical Press |
publishDate |
2011 |
url |
https://doaj.org/article/c39c876695004519b25417e3291cafda |
work_keys_str_mv |
AT udaondop intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion AT garciadelpechs intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion AT salomd intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion AT garciapousm intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion AT diazllopism intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion |
_version_ |
1718396015489318912 |